Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and speed of onset of 2mg intravenous
hydromorphone (Dilaudid) in patients weighing at least 150 lbs presenting to the emergency
department with acute severe pain